Compare VRA & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRA | TVGN |
|---|---|---|
| Founded | 1982 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 63.9M |
| IPO Year | 2010 | N/A |
| Metric | VRA | TVGN |
|---|---|---|
| Price | $2.72 | $0.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 233.3K | ★ 635.2K |
| Earning Date | 03-11-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $324,296,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $0.23 |
| 52 Week High | $3.52 | $1.69 |
| Indicator | VRA | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 32.16 |
| Support Level | $2.52 | $0.23 |
| Resistance Level | $2.80 | $0.26 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 59.41 | 22.18 |
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.